Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Akorn, Inc. (AKRX) A Good Stock To Buy?

Hedge funds run by legendary names like Nelson Peltz and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to have a minimum of $1 million liquid to invest in a hedge fund) by spending enormous resources on analyzing and uncovering data about small-cap stocks that the big brokerage houses don’t follow. Small caps are where they can generate significant outperformance. That’s why we pay special attention to hedge fund activity in these stocks.

Akorn, Inc. (NASDAQ:AKRX) shares haven’t seen a lot of action during the third quarter. Overall, hedge fund sentiment was unchanged. The stock was in 39 hedge funds’ portfolios at the end of September. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Alexander & Baldwin Inc (NYSE:ALEX), Atlas Air Worldwide Holdings, Inc. (NASDAQ:AAWW), and Corcept Therapeutics Incorporated (NASDAQ:CORT) to gather more data points.

At the moment there are several formulas shareholders employ to size up stocks. A couple of the less utilized formulas are hedge fund and insider trading moves. We have shown that, historically, those who follow the top picks of the top money managers can outclass the broader indices by a superb amount (see the details here).

Andrew Feldstein and Stephen Siderow, Blue Mountain Capital, BlueMountain Capital

We’re going to take a gander at the key hedge fund action encompassing Akorn, Inc. (NASDAQ:AKRX).

How have hedgies been trading Akorn, Inc. (NASDAQ:AKRX)?

At Q3’s end, a total of 39 of the hedge funds tracked by Insider Monkey were long this stock, no change from one quarter earlier. On the other hand, there were a total of 27 hedge funds with a bullish position in AKRX at the beginning of this year. So, let’s see which hedge funds were among the top holders of the stock and which hedge funds were making big moves.

No of Hedge Funds with AKRX Positions

According to Insider Monkey’s hedge fund database, Solus Alternative Asset Management, managed by Christopher Pucillo, holds the largest position in Akorn, Inc. (NASDAQ:AKRX). Solus Alternative Asset Management has a $54.8 million position in the stock, comprising 10% of its 13F portfolio. The second most bullish fund manager is Marshall Wace LLP, led by Paul Marshall and Ian Wace, holding a $38.9 million position; the fund has 0.3% of its 13F portfolio invested in the stock. Some other peers that are bullish consist of Michel Massoud’s Melqart Asset Management, Andrew Feldstein and Stephen Siderow’s Blue Mountain Capital and Jim Simons’s Renaissance Technologies.

Because Akorn, Inc. (NASDAQ:AKRX) has experienced a decline in interest from hedge fund managers, we can see that there was a specific group of funds who sold off their full holdings by the end of the third quarter. At the top of the heap, Brian J. Higgins’s King Street Capital cut the biggest position of all the hedgies followed by Insider Monkey, comprising about $21.6 million in stock, and Zach Schreiber’s Point State Capital was right behind this move, as the fund dropped about $20.8 million worth. These moves are intriguing to say the least, as total hedge fund interest stayed the same (this is a bearish signal in our experience).

Let’s go over hedge fund activity in other stocks – not necessarily in the same industry as Akorn, Inc. (NASDAQ:AKRX) but similarly valued. These stocks are Alexander & Baldwin Inc (NYSE:ALEX), Atlas Air Worldwide Holdings, Inc. (NASDAQ:AAWW), Corcept Therapeutics Incorporated (NASDAQ:CORT), and The Gabelli Equity Trust Inc. (NYSE:GAB). All of these stocks’ market caps match AKRX’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
ALEX 8 22147 -1
AAWW 15 140701 0
CORT 15 152727 -1
GAB 1 5589 -1
Average 9.75 80291 -0.75

View table here if you experience formatting issues.

As you can see these stocks had an average of 9.75 hedge funds with bullish positions and the average amount invested in these stocks was $80 million. That figure was $301 million in AKRX’s case. Atlas Air Worldwide Holdings, Inc. (NASDAQ:AAWW) is the most popular stock in this table. On the other hand Gabelli Equity Trust, Inc. (The) (NYSE:GAB) is the least popular one with only 1 bullish hedge fund positions. Compared to these stocks Akorn, Inc. (NASDAQ:AKRX) is more popular among hedge funds. Considering that hedge funds are fond of this stock in relation to its market cap peers, it may be a good idea to analyze it in detail and potentially include it in your portfolio.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...